Daniele Noviello

Mar 13, 2024 | bpno.dk | Daniele Noviello

marts 2024 This study, presented by Daniele Noviello, a gastroenterologist and PhD student at the University of Milan, focuses on the impact of different biological therapies on a subset of Th17 cells, known as pathogenic Th17 (pTh17) cells, in patients with Crohn’s disease. The research demonstrates that Risankizumab, unlike Ustekinumab or Vedolizumab, effectively downregulates IL-23-induced mucosal pTh17 cells in these patients.

May 9, 2023 | frontiersin.org | Angelo V. Marzano |Doreen E. Szollosi |Daniele Noviello |Guojiu Fang

Guojiu Fang, Fanzhi Kong, Haiqing Zhang, Bin Huang, Jifa Zhang*† and Xueli Zhang*†Department of General Surgery, Shanghai Fengxian Central Hospital, Shanghai, ChinaBackground: Mendelian randomization (MR) was used to evaluate the bidirectional causal relationship between inflammatory bowel disease (IBD) and interleukins (ILs), chemokines.